Literature DB >> 10524489

Parvovirus B19 infections.

C Sabella1, J Goldfarb.   

Abstract

Infections caused by human parvovirus B19 can result in a wide spectrum of manifestations, which are usually influenced by the patient's immunologic and hematologic status. In the normal host, parvovirus infection can be asymptomatic or can result in erythema infectiosum or arthropathy. Patients with underlying hematologic and immunologic disorders who become infected with this virus are at risk for aplastic anemia. Hydrops fetalis and fetal death are complications of intrauterine parvovirus B19 infection.

Entities:  

Mesh:

Year:  1999        PMID: 10524489

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  4 in total

1.  Study on clinical characteristics and follow-up visit of acquired aplastic anemia associated with parvovirus B19 infection.

Authors:  Jin-quan Wen; Nan Zhou; Dan Li; Hai-ling Feng; Hua Wang
Journal:  Indian J Pediatr       Date:  2011-08-10       Impact factor: 1.967

2.  Prevalence of antibodies to human parvovirus b19 in saudi women of childbearing age in makkah.

Authors:  Hani O Ghazi
Journal:  J Family Community Med       Date:  2007-01

3.  Pure red cell aplasia associated with parvovirus B19 infection in a patient with ulcerative colitis.

Authors:  Hajime Isomoto; Yasuhiro Fukuda; Yumiko Bando; Ikuko Machida; Haruhisa Machida; Katsuhisa Omagari; Yohei Mizuta; Kunihiko Murase; Takuya Fukushima; Ikuo Murata; Shigeru Kohno
Journal:  Dig Dis Sci       Date:  2003-10       Impact factor: 3.487

4.  Therapeutic implications of a combined diagnostic workup including endomyocardial biopsy in an all-comer population of patients with heart failure: a retrospective analysis.

Authors:  Efthymios Sotiriou; Susanne Heiner; Thomas Jansen; Moritz Brandt; Kai Helge Schmidt; Karl-Friedrich Kreitner; Tilman Emrich; Heinz-Peter Schultheiss; Eberhard Schulz; Thomas Münzel; Philip Wenzel
Journal:  ESC Heart Fail       Date:  2018-05-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.